Perhaps she didn't step up as would be expected of a senior executive when Esra hit the fan - Harry coming back full time but not as CEO and who has certainly stepped up - possibly its a game of musical chairs with only so many senior roles/salaries to go around. As for who will run phase 2/3 I think we will find our new ceo's credentials are heavily weighted towards someone who is able to prove their ability to push a drug through trials to commericialbility......rather than being a pure business type from an unrelated industry......I get the feeling this new CEO will be very hands on - something as it turns out our last CEO wasn't (wasn't at the negotiation table or the lab) ---unless you count the hands in the till!!!
- Forums
- ASX - By Stock
- new ceo and board 'business model'
Perhaps she didn't step up as would be expected of a senior...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.366K | 455.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
60 | 99145902 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 22467224 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 99145902 | 0.002 |
20 | 74250508 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 22467224 | 7 |
0.004 | 24316867 | 21 |
0.005 | 27709765 | 14 |
0.006 | 19365067 | 10 |
0.007 | 9365221 | 8 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |